PVR and neoplasm: While the presence of KIR2DL5 dramatically suppressed NK cytolytic activity against PVR+ tumor cells (scrambled control), this effect was eliminated upon the deletion of PVR in tumor cells by CRISPR/Cas9 (PVRKO) (Figure 4D and Supplemental Figure 5, F and G).